busulfan has been researched along with Blastocyst Disintegration in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg/kg/day; n = 10 in each group) for 2 or 4 weeks to assess the optimal administration period for detection of the toxic effects on ovarian morphology." | 1.35 | Collaborative work on evaluation of ovarian toxicity. 5) Two- or four-week repeated-dose studies and fertility study of busulfan in female rats. ( Iwasaki, S; Kudo, S; Masumoto, Y; Miyata, Y; Nishi, M; Sakurada, Y, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakurada, Y | 1 |
| Kudo, S | 1 |
| Iwasaki, S | 1 |
| Miyata, Y | 1 |
| Nishi, M | 1 |
| Masumoto, Y | 1 |
1 other study available for busulfan and Blastocyst Disintegration
| Article | Year |
|---|---|
Collaborative work on evaluation of ovarian toxicity. 5) Two- or four-week repeated-dose studies and fertility study of busulfan in female rats.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers; Busulfan; Drug Administration Schedule; Embr | 2009 |